Las Vegas, NV -- (SBWIRE) -- 01/06/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Athersys, Inc. (NASDAQ:ATHX), IAMGOLD Corp (USA) (NYSE:IAG), Groupon Inc (NASDAQ:GRPN), Mast Therapeutics Inc (NYSEMKT:MSTX).
Athersys, Inc. (NASDAQ:ATHX) ended its recent business day with the tumbled of -2.71% and closed at the price of $2.87 after opening at $2.98. The stock traded during its last trading session with the total volume of 3.45 million shares, as compared to its average volume of 1.51 million shares. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine.
Has ATHX Found The Bottom And Ready To Gain Momentum? Find Out Here
IAMGOLD Corp (USA) (NYSE:IAG) remained among the day bearish -0.85% and traded with volume of 5.87 million shares in the last session, as compared to average volume of 7.22 million shares. In comparison with 52 week range of $3.15 - $11.22, it faced lowest price of $3.49 during the last trading session whereas its day highest price was $3.61. The company’s total market capitalization is $1.32 billion, along with 376.64 million shares outstanding. IAMGOLD Corporation engages in the exploration, development, and operation of mining properties.
Why Should Investors Buy IAG After the Recent Fall? Just Go Here and Find Out
Groupon Inc (NASDAQ:GRPN) showed 24.27 million shares in volume during the last trading session, while the average trading volume remained 18.11 million shares. The stock kicked off its trading session at $11.63 and closed at $12.08 after rallied 1.94%. Groupon, Inc. operates as a local commerce marketplace that connects merchants to consumers by offering goods and services at a discount in North America and internationally.
Why Should Investors Buy GRPN After The Recent Gain? Just Go Here and Find Out
Mast Therapeutics Inc (NYSEMKT:MSTX) stock traded during its last trading session with the total traded volume of 3.35 million shares versus its average volume of 1.12 million shares. The company opened its trade at the price of $0.49 and its closing price was $0.500 after gained 5.78% for the day. Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases.
For How Long MSTX will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)